State Street’s Harvard Bioscience HBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $72.7K | Sell |
14,932
-3
| -0% | -$17 | ﹤0.01% | 4081 |
|
|
2025
Q4 | $99.9K | Hold |
14,935
| – | – | ﹤0.01% | 4048 |
|
|
2025
Q3 | $65.5K | Hold |
14,935
| – | – | ﹤0.01% | 4120 |
|
|
2025
Q2 | $66.3K | Sell |
14,935
-59,589
| -80% | -$249K | ﹤0.01% | 4046 |
|
|
2025
Q1 | $422K | Buy |
74,524
+263
| +0.4% | +$3.37K | ﹤0.01% | 3631 |
|
|
2024
Q4 | $1.57M | Buy |
74,261
+2,522
| +4% | +$57.9K | ﹤0.01% | 3386 |
|
|
2024
Q3 | $1.93M | Buy |
71,739
+777
| +1% | +$22.9K | ﹤0.01% | 3343 |
|
|
2024
Q2 | $2.02M | Buy |
70,962
+1,639
| +2% | +$57.5K | ﹤0.01% | 3315 |
|
|
2024
Q1 | $2.94M | Buy |
69,323
+1,081
| +2% | +$48.6K | ﹤0.01% | 3142 |
|
|
2023
Q4 | $3.65M | Buy |
68,242
+1,434
| +2% | +$64.7K | ﹤0.01% | 3093 |
|
|
2023
Q3 | $2.87M | Buy |
66,808
+4,120
| +7% | +$190K | ﹤0.01% | 3172 |
|
|
2023
Q2 | $3.44M | Buy |
62,688
+49,933
| +391% | +$2.74M | ﹤0.01% | 3174 |
|
|
2023
Q1 | $536K | Hold |
12,755
| – | – | ﹤0.01% | 3719 |
|
|
2022
Q4 | $353K | Hold |
12,755
| – | – | ﹤0.01% | 3889 |
|
|
2022
Q3 | $327K | Hold |
12,755
| – | – | ﹤0.01% | 3931 |
|
|
2022
Q2 | $459K | Sell |
12,755
-61,538
| -83% | -$2.78M | ﹤0.01% | 3858 |
|
|
2022
Q1 | $4.61M | Buy |
74,293
+3,917
| +6% | +$232K | ﹤0.01% | 3221 |
|
|
2021
Q4 | $4.96M | Buy |
70,376
+1,806
| +3% | +$128K | ﹤0.01% | 3244 |
|
|
2021
Q3 | $4.79M | Sell |
68,570
-180
| -0.3% | -$14.3K | ﹤0.01% | 3261 |
|
|
2021
Q2 | $5.73M | Buy |
68,750
+9,147
| +15% | +$647K | ﹤0.01% | 3182 |
|
|
2021
Q1 | $3.25M | Sell |
59,603
-4,068
| -6% | -$198K | ﹤0.01% | 3233 |
|
|
2020
Q4 | $2.73M | Buy |
63,671
+17,238
| +37% | +$643K | ﹤0.01% | 3236 |
|
|
2020
Q3 | $1.4M | Buy |
46,433
+4,647
| +11% | +$156K | ﹤0.01% | 3339 |
|
|
2020
Q2 | $1.29M | Buy |
41,786
+40,640
| +3,546% | +$1.09M | ﹤0.01% | 3345 |
|
|
2020
Q1 | $25K | Sell |
1,146
-3,079
| -73% | -$83.4K | ﹤0.01% | 3691 |
|
|
2019
Q4 | $129K | Buy |
4,225
+379
| +10% | +$10.9K | ﹤0.01% | 3667 |
|
|
2019
Q3 | $118K | Buy |
3,846
+111
| +3% | +$2.76K | ﹤0.01% | 3656 |
|
|
2019
Q2 | $75K | Sell |
3,735
-48,273
| -93% | -$1.41M | ﹤0.01% | 3692 |
|
|
2019
Q1 | $2.24M | Buy |
52,008
+1,764
| +4% | +$64K | ﹤0.01% | 3113 |
|
|
2018
Q4 | $1.6M | Sell |
50,244
-1,270
| -2% | -$50.1K | ﹤0.01% | 3203 |
|
|
2018
Q3 | $2.7M | Buy |
51,514
+3,780
| +8% | +$212K | ﹤0.01% | 3140 |
|
|
2018
Q2 | $2.55M | Buy |
47,734
+45,174
| +1,765% | +$2.31M | ﹤0.01% | 3161 |
|
|
2018
Q1 | $128K | Buy |
2,560
+257
| +11% | +$11.5K | ﹤0.01% | 3595 |
|
|
2017
Q4 | $77K | Buy |
2,303
+853
| +59% | +$28.8K | ﹤0.01% | 3617 |
|
|
2017
Q3 | $55K | Hold |
1,450
| – | – | ﹤0.01% | 3658 |
|
|
2017
Q2 | $37K | Hold |
1,450
| – | – | ﹤0.01% | 3613 |
|
|
2017
Q1 | $38K | Hold |
1,450
| – | – | ﹤0.01% | 3589 |
|
|
2016
Q4 | $45K | Hold |
1,450
| – | – | ﹤0.01% | 3573 |
|
|
2016
Q3 | $41K | Hold |
1,450
| – | – | ﹤0.01% | 3499 |
|
|
2016
Q2 | $42K | Sell |
1,450
-30,214
| -95% | -$961K | ﹤0.01% | 3596 |
|
|
2016
Q1 | $955K | Buy |
31,664
+1,701
| +6% | +$48.2K | ﹤0.01% | 3227 |
|
|
2015
Q4 | $1.04M | Buy |
29,963
+1,259
| +4% | +$43.1K | ﹤0.01% | 3200 |
|
|
2015
Q3 | $1.08M | Buy |
28,704
+1,514
| +6% | +$70.4K | ﹤0.01% | 3190 |
|
|
2015
Q2 | $1.55M | Buy |
27,190
+25,690
| +1,713% | +$1.46M | ﹤0.01% | 3145 |
|
|
2015
Q1 | $87K | Hold |
1,500
| – | – | ﹤0.01% | 3551 |
|
|
2014
Q4 | $85K | Sell |
1,500
-150
| -9% | -$7.15K | ﹤0.01% | 3551 |
|
|
2014
Q3 | $68K | Hold |
1,650
| – | – | ﹤0.01% | 3542 |
|
|
2014
Q2 | $75K | Sell |
1,650
-31,778
| -95% | -$1.34M | ﹤0.01% | 3499 |
|
|
2014
Q1 | $1.58M | Buy |
33,428
+1,086
| +3% | +$49.4K | ﹤0.01% | 3145 |
|
|
2013
Q4 | $1.52M | Sell |
32,342
-10,254
| -24% | -$448K | ﹤0.01% | 3166 |
|
|
2013
Q3 | $1.7M | Sell |
42,596
-4,824
| -10% | -$190K | ﹤0.01% | 3107 |
|
|
2013
Q2 | $1.7M | Buy |
+47,420
| New | +$1.82M | ﹤0.01% | 3053 |
|
Other funds holding HBIO
WCM
VCM
CCM
MIM
NCNMGF
